| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0088 | 1 |